{"id":"W4391482982","doi":"10.1038/s41408-023-00966-9","title":"GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review","year":2024,"lang":"en","type":"review","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Research and Development","keywords":"Medicine; Multiple myeloma; Chimeric antigen receptor; Clinical trial; Adverse effect; Pharmacodynamics; Malignancy; Cytokine release syndrome; Immunotherapy; Oncology; Antigen; Internal medicine; Pharmacokinetics; Immunology; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003678451,0.0006285414,0.002725101,0.0002102364,0.0002439833,0.00005564879,0.0002730764,0.0001770724,0.0004105895],"category_scores_gemma":[0.000284605,0.0002835387,0.002121454,0.0004240643,0.0001079798,0.00004983749,0.00003940053,0.0005503907,0.00004056393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005604199,"about_ca_system_score_gemma":0.003166091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001239798,"about_ca_topic_score_gemma":0.00004604613,"domain_scores_codex":[0.9972479,0.0001175282,0.00101027,0.0004427672,0.0006345751,0.0005469808],"domain_scores_gemma":[0.9976019,0.0005389023,0.0006168,0.0004812877,0.0003826179,0.0003785171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001707183,0.001303477,0.0000151336,0.05911493,0.01337934,0.0002989864,0.0003906662,2.688844e-7,0.000003343152,0.00001266607,0.007810505,0.9175],"study_design_scores_gemma":[0.004332084,0.002574465,0.000004655225,0.1022958,0.02367442,0.002267899,0.00006244255,0.00001481642,0.0000235928,0.00001586631,0.8645443,0.0001897011],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001050158,0.9920326,0.0000379109,0.0008708197,0.0005116437,0.005485606,0.000873187,0.00002000931,0.0001576984],"genre_scores_gemma":[0.00001408863,0.9906043,0.0009579505,0.00009301802,0.001307608,0.00343888,0.0001160468,0.0001017393,0.003366415],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9173102,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028294294267789,"score_gpt":0.4423208833592079,"score_spread":0.339491453932429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}